Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has remained flat, although notably Hofseth BioCare gained 7.8%. Unfortunately though, the industry is down 56% over the past 12 months. As for the next few years, earnings are expected to grow by 24% per annum.
Has the Norwegian Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 14 Feb 2025 | NOK 5.1b | NOK 457.3m | -NOK 1,122,407,354.72 | 172.6x | -4.5x | 11.2x |
Sun, 12 Jan 2025 | NOK 4.6b | NOK 458.1m | -NOK 1,078,107,616.98 | 157.4x | -4.3x | 10.1x |
Tue, 10 Dec 2024 | NOK 4.3b | NOK 456.5m | -NOK 1,064,255,412.26 | 146.8x | -4.1x | 9.5x |
Thu, 07 Nov 2024 | NOK 4.1b | NOK 472.9m | -NOK 1,075,132,975.80 | 48.2x | -3.9x | 8.8x |
Sat, 05 Oct 2024 | NOK 5.0b | NOK 470.1m | -NOK 1,059,165,831.85 | 58.9x | -4.7x | 10.7x |
Mon, 02 Sep 2024 | NOK 6.0b | NOK 471.3m | -NOK 1,035,118,355.30 | 66.3x | -5.8x | 12.7x |
Wed, 31 Jul 2024 | NOK 9.3b | NOK 517.3m | -NOK 1,054,492,149.61 | 74.9x | -8.8x | 17.9x |
Fri, 28 Jun 2024 | NOK 9.1b | NOK 642.0m | -NOK 942,400,959.21 | 37.4x | -9.6x | 14.1x |
Sun, 26 May 2024 | NOK 9.0b | NOK 630.4m | -NOK 976,448,522.34 | 38.6x | -9.2x | 14.3x |
Tue, 23 Apr 2024 | NOK 8.6b | NOK 660.3m | -NOK 962,444,295.74 | 37.4x | -8.9x | 13x |
Thu, 21 Mar 2024 | NOK 8.9b | NOK 654.7m | -NOK 934,223,461.60 | 39.2x | -9.6x | 13.6x |
Sat, 17 Feb 2024 | NOK 15.1b | NOK 671.9m | -NOK 1,003,515,434.30 | 37.4x | -15.1x | 22.5x |
Mon, 15 Jan 2024 | NOK 16.4b | NOK 654.1m | -NOK 1,352,223,251.00 | 59.2x | -12.1x | 25x |
Wed, 13 Dec 2023 | NOK 15.2b | NOK 664.1m | -NOK 1,381,204,144.00 | 58.5x | -11x | 22.9x |
Fri, 10 Nov 2023 | NOK 14.4b | NOK 620.2m | -NOK 1,471,136,123.00 | 57.4x | -9.8x | 23.2x |
Sun, 08 Oct 2023 | NOK 14.6b | NOK 627.1m | -NOK 1,464,513,549.00 | 49.6x | -10x | 23.4x |
Tue, 05 Sep 2023 | NOK 15.8b | NOK 625.9m | -NOK 1,425,212,068.00 | 58.3x | -11.1x | 25.2x |
Thu, 03 Aug 2023 | NOK 15.9b | NOK 556.5m | -NOK 1,457,696,286.00 | 55.8x | -10.9x | 28.6x |
Sat, 01 Jul 2023 | NOK 15.1b | NOK 561.6m | -NOK 1,478,500,076.00 | 60.8x | -10.2x | 27x |
Mon, 29 May 2023 | NOK 17.1b | NOK 564.4m | -NOK 1,503,734,245.00 | 63.8x | -11.4x | 30.3x |
Wed, 26 Apr 2023 | NOK 16.9b | NOK 541.7m | -NOK 1,445,458,420.00 | 29.9x | -11.7x | 31.3x |
Fri, 24 Mar 2023 | NOK 15.2b | NOK 535.7m | -NOK 1,553,176,509.00 | 29.6x | -9.8x | 28.4x |
Sun, 19 Feb 2023 | NOK 18.3b | NOK 837.0m | -NOK 1,434,693,996.00 | 32.6x | -12.7x | 21.8x |
Tue, 17 Jan 2023 | NOK 18.4b | NOK 808.8m | -NOK 1,394,196,750.00 | 24.7x | -13.2x | 22.7x |
Thu, 15 Dec 2022 | NOK 20.9b | NOK 803.2m | -NOK 1,391,200,712.00 | 43x | -15x | 26x |
Sat, 12 Nov 2022 | NOK 18.7b | NOK 792.3m | -NOK 1,358,346,015.00 | 36.2x | -13.8x | 23.6x |
Mon, 10 Oct 2022 | NOK 17.6b | NOK 816.0m | -NOK 1,365,481,897.00 | 37.5x | -12.9x | 21.6x |
Wed, 07 Sep 2022 | NOK 19.7b | NOK 791.6m | -NOK 1,366,773,447.00 | 36.8x | -14.4x | 24.9x |
Fri, 05 Aug 2022 | NOK 22.1b | NOK 764.9m | -NOK 1,379,723,545.00 | 46.6x | -16x | 28.9x |
Sun, 03 Jul 2022 | NOK 19.5b | NOK 773.1m | -NOK 1,381,948,103.00 | 43x | -14.1x | 25.2x |
Tue, 31 May 2022 | NOK 22.3b | NOK 1.1b | -NOK 1,030,235,367.00 | 40.3x | -21.6x | 20.6x |
Thu, 28 Apr 2022 | NOK 23.1b | NOK 1.1b | -NOK 991,088,007.00 | 40.2x | -23.3x | 21.9x |
Sat, 26 Mar 2022 | NOK 26.5b | NOK 2.6b | NOK 374.4m | 10x | 70.8x | 10.1x |
Mon, 21 Feb 2022 | NOK 27.0b | NOK 2.7b | NOK 449.7m | 10.1x | 60.1x | 10x |
60.1x
Which industries have driven the changes within the Norwegian Healthcare industry?
NO Market | -1.37% | |
Healthcare | -1.08% | |
Biotech | -2.17% | |
Biotech | -2.17% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
AZT ArcticZymes Technologies | NOK 19.00 | 35.7% +NOK 255.4m | -29.0% | PE128.2x | |
PCIB PCI Biotech Holding | NOK 1.33 | 7.8% +NOK 3.6m | -30.8% | PS8.3x | |
ULTI Ultimovacs | NOK 2.10 | 0.5% +NOK 344.1k | -98.5% | PB0.9x |